*The 2020 edition of this event has now run. Thanks to all the participants!*

The 4th Annual PREDiCT: Tumor Models San Francisco Summit 2020 continued to serve immuno-oncology scientific community, helping them to gain a better understanding of candidate and preclinical profiling through robust selection of models and use of cutting-edge technologies. Attendees explored the opportunities and limitations of syngenic and PDX mouse models, the potential of 3D models and gain a comprehensive understanding of novel technologies and imaging techniques that are changing the preclinical and translational field.

This is your ONLY dedicated preclinical model summit that focuses on practical case studies and open collaboration, providing you with unparalleled takeaways to accelerate your drug development program.

Take a look at the 2020 Full Event Guide here.

"This was a great conference for staying on top of some of the latest developments in IO models and getting a better understanding of the various models, their utility and limitations. The size of the conference allows for many fruitful discussions and ease of meeting with several of the major CROs that provide models for those in the immuno-oncology space."

Michael Mattie, Associate Director, Translational Medicine, Kite Pharma

Expert Speakers at the 2020 PREDiCT: Tumor Models San Francisco Summit included:

2020 Official Sponsors:

Lead Partner:

Hosting Partner:

Jackson-Laboratory
Crown
Champions_Logo_Final
GenOway
Covance
Hera-BioLabs-resize
Pharmatest-logo-2015
Proqinase + RBC (1)
studylog_logo-tag-cropped
TriFoil
RE_LOGO_CMYK-2
bioduro_logo__orange_box_cmyk

Official 2020 Media Partners:

CLSA_LOGO_RGB
Print
voicelogo
Pharmaceutical-logo